AKT1 and cancer: From these results, we concluded that the anti-OP IPRN is mainly involved in the PI3K-Akt signaling pathway, AGE-RAGE signaling pathway in diabetic complications, proteoglycans in cancer, TNF signaling pathway, and other biological pathways.